DBTX Annual FCF
-$57.36 M
-$13.47 M-30.68%
31 December 2022
Summary:
As of February 2, 2025, DBTX annual free cash flow is -$57.36 million, with the most recent change of -$13.47 million (-30.68%) on December 31, 2022. During the last 3 years, it has fallen by -$7.23 million (-14.42%).DBTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX Quarterly FCF
-$10.26 M
+$7.07 M+40.79%
30 June 2023
Summary:
As of February 2, 2025, DBTX quarterly free cash flow is -$10.26 million, with the most recent change of +$7.07 million (+40.79%) on June 30, 2023. Over the past year, it has increased by +$3.27 million (+24.19%).DBTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX TTM FCF
-$49.30 M
+$3.27 M+6.22%
30 June 2023
Summary:
As of February 2, 2025, DBTX TTM free cash flow is -$49.30 million, with the most recent change of +$3.27 million (+6.22%) on June 30, 2023. Over the past year, it has increased by +$8.17 million (+14.22%).DBTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.7% | +24.2% | +14.2% |
| 3 y3 years | -14.4% | -27.9% | -146.8% |
| 5 y5 years | -53.5% | - | - |
DBTX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +74.2% | +94.9% | +312.2% |
Decibel Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$10.26 M(-40.8%) | -$49.30 M(-6.2%) |
| Mar 2023 | - | -$17.32 M(+117.5%) | -$52.58 M(-8.3%) |
| Dec 2022 | -$57.36 M(+30.7%) | -$7.96 M(-42.1%) | -$57.36 M(-3.2%) |
| Sept 2022 | - | -$13.76 M(+1.7%) | -$59.27 M(+3.1%) |
| June 2022 | - | -$13.53 M(-38.8%) | -$57.47 M(+15.8%) |
| Mar 2022 | - | -$22.11 M(+124.0%) | -$49.63 M(+13.1%) |
| Dec 2021 | -$43.90 M | -$9.87 M(-17.5%) | -$43.90 M(+11.7%) |
| Sept 2021 | - | -$11.97 M(+110.5%) | -$39.29 M(+12.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$5.69 M(-65.3%) | -$35.01 M(-6.2%) |
| Mar 2021 | - | -$16.37 M(+211.2%) | -$37.34 M(+13.4%) |
| Dec 2020 | -$32.93 M(-34.3%) | -$5.26 M(-31.6%) | -$32.93 M(+19.0%) |
| Sept 2020 | - | -$7.69 M(-4.1%) | -$27.67 M(+38.5%) |
| June 2020 | - | -$8.02 M(-33.0%) | -$19.98 M(+67.0%) |
| Mar 2020 | - | -$11.96 M | -$11.96 M |
| Dec 2019 | -$50.13 M(+34.2%) | - | - |
| Dec 2018 | -$37.37 M | - | - |
FAQ
- What is Decibel Therapeutics annual free cash flow?
- What is the all time high annual FCF for Decibel Therapeutics?
- What is Decibel Therapeutics annual FCF year-on-year change?
- What is Decibel Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Decibel Therapeutics?
- What is Decibel Therapeutics quarterly FCF year-on-year change?
- What is Decibel Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Decibel Therapeutics?
- What is Decibel Therapeutics TTM FCF year-on-year change?
What is Decibel Therapeutics annual free cash flow?
The current annual FCF of DBTX is -$57.36 M
What is the all time high annual FCF for Decibel Therapeutics?
Decibel Therapeutics all-time high annual free cash flow is -$32.93 M
What is Decibel Therapeutics annual FCF year-on-year change?
Over the past year, DBTX annual free cash flow has changed by -$13.47 M (-30.68%)
What is Decibel Therapeutics quarterly free cash flow?
The current quarterly FCF of DBTX is -$10.26 M
What is the all time high quarterly FCF for Decibel Therapeutics?
Decibel Therapeutics all-time high quarterly free cash flow is -$5.26 M
What is Decibel Therapeutics quarterly FCF year-on-year change?
Over the past year, DBTX quarterly free cash flow has changed by +$3.27 M (+24.19%)
What is Decibel Therapeutics TTM free cash flow?
The current TTM FCF of DBTX is -$49.30 M
What is the all time high TTM FCF for Decibel Therapeutics?
Decibel Therapeutics all-time high TTM free cash flow is -$11.96 M
What is Decibel Therapeutics TTM FCF year-on-year change?
Over the past year, DBTX TTM free cash flow has changed by +$8.17 M (+14.22%)